RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @fukushimah: ワクチンだめじゃん
ワクチンだめじゃん
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
RT @influenzer3: 理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a…
理論的には南アフリカ変異株、ブラジル変異株に対しては感染防御能が著しく低下するかと。 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial https://t.co/u9JevRecyC
@gerrard1212 @Thomas_Binder @FatEmperor Have you read the data from AstraZeneca? They do not know if the vaccine offers long term immunity or if it provides immunity at all or what the long term health effects will be. https://t.co/KTPOuCd4vM https://t.
@MiRo_SPD Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet https://t.co/AKrqFsDms0
So, the creator of the Covid-19 vaccine trial also stands to gain financially with a patent and the other trial creator works for the WHO. Under contributors and declaration of interests https://t.co/qinT9Nt0Jn
@FLermyte @florian_krammer pretty sure it's WT spike without the 2P https://t.co/XAh714yIzS
@lvdl01 @Kenpachi_Trader @SAHPRA1 @matthews_johann 1) Animal trial of AZ/Oxford vaccine: https://t.co/dz1K2jAoZv & as a bonus, phase1/2 human trial: https://t.co/mbffVqvhbw Anaphylaxis in Pfizer vaccine is very rare and treatable: https://t.co/GrPWCtBT
I request you to not get caught up with this and support our healthcare workers and govt for their continued efforts. Link to publication of vaccine trials in Lancet https://t.co/GufwAMEMen https://t.co/90Ip51BVEm
@indepdubnrth Is the Oxford-AstraZeneca vaccine any safer, and if so why, please? It also introduces genetic material into our cells to cause them to produce the spike protein. DNA rather than RNA apparently but what difference does that make? https://t.c
@Muallimsays These are the safety and efficacy study results of #oxfordastrazeneca as published by @WHO https://t.co/aloJjDmwcg
@idieyidot link for Astrazeneca's phase 1/2 https://t.co/lGI0srIvg2 link for Sinovac's phase 1/2 https://t.co/7zXTjSJUC1
@mabelyang @BoffinNoddy That’s why there was a randomized safety study with 1,000 participants done specifically as part of Phase I of COVID vaccine trials. https://t.co/3yLY6P7pMH
RT @VernersViews: The study is published in The Lancet. This shows that because the side effects initially were so severe, all the subseque…
O estudo foi publicado no The Lancet. E mostrou que, como os efeitos colaterais inicialmente foram muito graves, todos os voluntários subsequentes da vacina receberam uma alta dose de paracetamol antes de receber a vacina https://t.co/PMi7F5JeJm… 7/8
RT @VernersViews: The study is published in The Lancet. This shows that because the side effects initially were so severe, all the subseque…
The study is published in The Lancet. This shows that because the side effects initially were so severe, all the subsequent test subjects for the vaccine were given a high dose of paracetamol [acetaminophen]. https://t.co/4pmmTBTrOg 7/8
@sci_questions @zchagla @UrbanHealthProf 'As previously reported,10 anti-vector immunity was low before vaccination in UK adults aged 18–55 years, with no relationship between the presence of antibodies to ChAdOx1 and immune response to the vaccine antigen
@ThomMohr @ShaliniVarma11 @RobertKennedyJr Meningococcal vaccine used! Link to Astra Zeneca trial. Placebo listed in 2nd paragraph, under methods: https://t.co/MZ4S6rlk51
@jeremychrysler @tim_quigley I think Pfizer has them beat, but not by much. Looks better than the Astrazeneca data. (Fig 5, ref to Convalescent response which is also in Pfizer figure). https://t.co/jm4xEfK7Jm
OXFORD ASTRASENECA https://t.co/iCV2OxOlq9
RT @YonSolitary: @RanaKumbha @Firezstarter1 @dlifein @ShaunakSA @RijoMJohn @MonkofMaude Try this thread This is on Oxford Astra Zeneca ak…
RT @NiteenWairagkar: #VaccinesForAll- assays used show titres of 51 (PHE MNA80), 218 (PHE PRNT50), 29 (Marburg VN) or 136 (PHE MNA80) with…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
@Northernbred1 Incase you missed it. I know this might tax your brain a little. Perhaps passing it to an adult might help in the translation 😂🤣😂 https://t.co/hSn799WiwM
@Northernbred1 Ignore the subject of the Oxford trials and injurys. In the meantime, here's some light reading. Don't pretend you know what your speaking about when it's very apparent you simply don't. And please stop stamping you feet. It's embarrassing..
@JohnSmi50968113 @afneil Here is Phase I (safety) https://t.co/aAIL9vcwnm Here are the combined results of Phase I and Phase II: https://t.co/y4lE1MZbrg
@81ef7ee82bd4478 @morhijo @norabar Aprende a leer y después hablamos. Si ni podes hacer la cuenta de que porcentaje representan esos 11 x millón y venis a hablar de ciencia y vacunas. No podrías leer un paper en toda tu vida, te dejo uno sobre el uso de ad
@capthss @YayathiPuru AstraZeneca-Oxford study didn't just dose all participants with prophylactic paracetamol, it did so at 2 of 5 trial sites and controlled for it https://t.co/4nlYQmVLBb
(5) אבל למזלנו יש את אוקספורד! אוקספורד פרסמו באוגוסט תוצאות של שלב 1 שבו הם הראו שהנוגדנים המנטרלים מגיעים רק אחרי המנה השניה, בדיוק כמו אצל פייזר ומודרנא. https://t.co/n8hDrokH4E https://t.co/E7oTNT2q6y
#Safety and #immunogenicity of the #ChAdOx1 #nCoV19 #vaccine against #SARSCoV2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial https://t.co/gHszKa03vH | via @TheLancet
@nde_ajurare @PortilloHJ "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet" https://t.co/xxXLDXdvRw
Ecco i trials di Oxford e Pfizer: Oxford: vax a vettore virale, test dai 18 ai 55 anni. Placebo con MenACWY Pfizer: vax a mRNA in nanoparticelle lipidiche. Test da 16 anni in su. Placebo, salina. Nel Pfizer, 162 "casi" (almeno 1 sintomo) con placebo (0,74%
RT @matteo_rivi: Ecco l'articolo di theLancet che parla del "successo" della prima fase di sperimentazione del vaccino di Oxford. Al capito…
♥️ science.
2020-07-20 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial https://t.co/NDrIYQHG8Y Next ...
RT @AlessandroLoio2: PARA QUE VOCÊ TOME NOTA A Vacina de Oxford utiliza um vetor viral (um adenovirus de chimpanzé) contendo uma proteína…
RT @podehaye: The rest is history: once COVID arrived, they had all the understanding they needed in order to design a vaccine (and for onc…
RT @podehaye: The rest is history: once COVID arrived, they had all the understanding they needed in order to design a vaccine (and for onc…
RT @AlessandroLoio2: PARA QUE VOCÊ TOME NOTA A Vacina de Oxford utiliza um vetor viral (um adenovirus de chimpanzé) contendo uma proteína…
RT @podehaye: The rest is history: once COVID arrived, they had all the understanding they needed in order to design a vaccine (and for onc…
RT @podehaye: The rest is history: once COVID arrived, they had all the understanding they needed in order to design a vaccine (and for onc…
RT @podehaye: The rest is history: once COVID arrived, they had all the understanding they needed in order to design a vaccine (and for onc…
The rest is history: once COVID arrived, they had all the understanding they needed in order to design a vaccine (and for once the resources for this). The Oxford COVID vaccine is based on ChAdOx1. https://t.co/obZZYG44NB
@anandcpatel @DrEricDing https://t.co/U6Z18j4JkS This is one journal publishing findings. Efficacy has been verified for the split dose. You call it an error, most others call it a positive finding. 33% improvement in efficacy is a massive boon
RT @AlisonBlunt: @eileeniorio @philosopherssto @SeymourClearly5 I've not seen that paper, but it's rare for medical trials to involve purel…
@eileeniorio @philosopherssto @SeymourClearly5 I've not seen that paper, but it's rare for medical trials to involve purely saline placebos, 'control' & 'placebo' are misleasing words. Eg, this study cites a comparison 'with a meningococcal conjugate v
Tu ja pensou quando Bolsonaro descobrir isso? Vai dizer que nao se responsabiliza se alguem tomar e virar um macaco https://t.co/ddrFO5RlNt